Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New hope for kidney stone sufferers: drug and diet combo tested in major trial

NCT ID NCT06653738

First seen May 28, 2026 · Last updated Jun 18, 2026 · Updated 7 times

Summary

This study tests two approaches to prevent kidney stones from coming back in people who have had them before. One approach uses a daily pill called empagliflozin (a diabetes drug) and the other gives personalized diet advice based on urine tests. The trial will involve 400 adults with calcium-based kidney stones and will last 3 years.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KIDNEY STONE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Charité University Medicine Berlin

    Berlin, 10117, Germany

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hôpital Européen Georges Pompidou

    Paris, 75908, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hôpital Tenon

    Paris, 75020, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Inselspital Bern

    Bern, 3010, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Kantonsspital Aarau

    Aarau, 5001, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Kantonsspital Baden

    Baden, 5404, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Kantonsspital Chur

    Chur, 7000, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Kantonsspital Fribourg

    Fribourg, 1708, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Kantonsspital Luzern

    Lucerne, 6016, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Kantonsspital Neuchâtel

    Neuchâtel, 2000, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Kantonsspital Olten

    Olten, 4600, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Kantonsspital Sion

    Sion, 1950, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Kantonsspital St. Gallen

    Sankt Gallen, 9007, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Lausanne University Hospital (CHUV)

    Lausanne, 1011, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Regionalspital Lugano

    Lugano, 6900, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University Hospital Amiens-Picardie

    Amiens, 80054, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University Hospital Basel

    Basel, 4031, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University Hospital Geneva (HUG)

    Geneva, 1211, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Università della Campania "Luigi Vanvitelli"

    Naples, 80131, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Universitätsspital Zürich

    Zurich, 8091, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Verona University Hospital

    Verona, 37134, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

Kidney Calculi nephrolithiasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.